Jin-kai Z. Feng
225 Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: February 12, 2026
Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.
Journal: The oncologist
Published: December 01, 2025
Transarterial chemoembolization combined with immune checkpoint inhibitors and anti-VEGF agents for intermediate HCC: a multicenter study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: July 25, 2025
Grading risk of microvascular invasion impacts survival in hepatocellular carcinoma patients undergoing adjuvant transarterial chemoembolization: A multicenter study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 25, 2025
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 05, 2024
Adjuvant transarterial chemoembolization plus lenvatinib for patients with HCC with MVI after resection: a multicenter retrospective study.
Journal: The oncologist
Published: March 08, 2024
Comment on "Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma".
Comment on "Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma".
Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: February 19, 2024
Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis.
Journal: Molecular biotechnology
Published: January 19, 2024
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence.
Journal: Technology in cancer research & treatment
Published: November 07, 2023
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Journal: The oncologist
Published: October 04, 2023
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma.
Journal: Hepatic medicine : evidence and research
Published: August 16, 2023
Last Updated: 09/26/2026